Vera Therapeutics, Inc. (VERA) has 9 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 2 sales totalling $2.7M. Most recent filing: Sept. 17, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 17, 2026 filed Sept. 15, 2026 | Fordyce Marshall PRESIDENT AND CEO | $630,909 | 55,500 | 0% | Yes | |
|
|
||||||
| Sept. 14, 2026 filed Sept. 11, 2026 | Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR | $19,698 | 10,000 | +17% | No | |
|
|
||||||
| Sept. 4, 2026 filed Sept. 2, 2026 | Fordyce Marshall PRESIDENT AND CEO | $596,052 | 55,500 | 0% | Yes | |
|
|
||||||
| Aug. 12, 2026 filed July 7, 2026 | Fordyce Marshall PRESIDENT AND CEO | $1,822,210 | 138,750 | 0% | Yes | |
|
|
||||||
| Aug. 12, 2026 filed June 23, 2026 | Fordyce Marshall PRESIDENT AND CEO | $648,178 | 55,500 | 0% | Yes | |
|
|
||||||
Showing the 5 most recent of 9 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free